Van beleggers
voor beleggers
desktop iconMarkt Monitor
  • Word abonnee
  • Inloggen

    Inloggen

    • Geen account? Registreren

    Wachtwoord vergeten?

Ontvang nu dagelijks onze kooptips!

word abonnee

Esperite 2018: het jaar van de waarheid

3.239 Posts
Pagina: «« 1 ... 81 82 83 84 85 ... 162 »» | Laatste | Omlaag ↓
  1. [verwijderd] 18 juni 2018 15:24
    ..Esperite with its biotech company The Cell Factory has acquired from OPBG the full rights to the IP and the international patent family covering the invention and the therapeutic use of the EV's products. In collaboration with Women's and Children's Health Department of the University of Padua, Italy they are presenting the new generation EV's biologic drugs bio-activated with Annexin V targeting multiple inflammatory diseases i.e.: Crohn's disease, drug resistance epilepsy, stroke. The experimental results will be presented during GISM congress in Assisi, Italy in April and ISEV meeting in Barcelona, Spain in May 2018

    heeft iem hier een verslag van..?
3.239 Posts
Pagina: «« 1 ... 81 82 83 84 85 ... 162 »» | Laatste |Omhoog ↑

Meedoen aan de discussie?

Word nu gratis lid of log in met je emailadres en wachtwoord.

Direct naar Forum

Indices

AEX 880,71 +0,68%
EUR/USD 1,0687 -0,14%
FTSE 100 8.078,40 +0,42%
Germany40^ 18.192,00 +0,30%
Gold spot 2.313,08 -0,39%
NY-Nasdaq Composite 15.696,64 +1,59%

Stijgers

VIVORY...
+22,08%
ASMI
+9,93%
NX FIL...
+6,41%
RANDST...
+4,07%
BESI
+3,56%

Dalers

ALLFUN...
-9,45%
ING
-4,85%
Flow T...
-2,64%
Avantium
-2,17%
DSM FI...
-1,60%

Lees verder op het IEX netwerk Let op: Artikelen linken naar andere sites

Gesponsorde links